- Report
- February 2023
- 162 Pages
Global
From €3955EUR$4,450USD£3,453GBP
- Report
- February 2022
- 167 Pages
Global
From €3955EUR$4,450USD£3,453GBP
- Report
- January 2022
- 148 Pages
Global
From €3955EUR$4,450USD£3,453GBP
- Report
- February 2024
- 120 Pages
Global
From €4222EUR$4,750USD£3,685GBP
- Report
- February 2024
- 110 Pages
Global
From €4222EUR$4,750USD£3,685GBP
- Report
- February 2024
- 125 Pages
Global
From €4222EUR$4,750USD£3,685GBP
- Report
- February 2024
- 120 Pages
Global
From €4222EUR$4,750USD£3,685GBP
- Report
- February 2024
- 140 Pages
Global
From €4222EUR$4,750USD£3,685GBP
- Report
- February 2024
- 120 Pages
Global
From €4222EUR$4,750USD£3,685GBP
- Report
- April 2023
- 120 Pages
Global
From €4222EUR$4,750USD£3,685GBP
- Report
- April 2023
- 70 Pages
Sweden
From €4222EUR$4,750USD£3,685GBP
- Report
- April 2023
- 85 Pages
United States
From €4222EUR$4,750USD£3,685GBP
- Report
- April 2023
- 120 Pages
Global
From €4222EUR$4,750USD£3,685GBP
- Report
- April 2023
- 69 Pages
India
From €4222EUR$4,750USD£3,685GBP
- Report
- April 2023
- 61 Pages
Mexico
From €4222EUR$4,750USD£3,685GBP
- Report
- March 2024
- 136 Pages
Global
From €3777EUR$4,250USD£3,297GBP
- Report
- January 2022
- 132 Pages
Global
From €3955EUR$4,450USD£3,453GBP
- Report
- October 2024
- 105 Pages
From €3066EUR$3,450USD£2,677GBP
- Report
- October 2024
- 114 Pages
North America
From €3066EUR$3,450USD£2,677GBP
- Report
- October 2024
- 109 Pages
Middle East, Africa
From €3066EUR$3,450USD£2,677GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more